Methotrexate also improves rheumatoid arthritis through correction of microbiota dysbiosis

This publication has 25 references indexed in Scilit:

• Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance
  Arthritis & Rheumatology, 2023
• Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
  iScience, 2022
• Tissue microbiota: A ‘secondary-self’, first target of autoimmunity?
  Joint Bone Spine, 2022
• The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease
  FEBS Open Bio, 2021
• Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson’s disease
  Cell Reports, 2021
• Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation
  Cell Host & Microbe, 2021
• The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis
  Arthritis & Rheumatology, 2020
• Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis
  Arthritis & Rheumatology, 2019
• Brief Report: Clinical Trials Aiming to Prevent Rheumatoid Arthritis Cannot Detect Prevention Without Adequate Risk Stratification: A Trial of Methotrexate Versus Placebo in Undifferentiated Arthritis as an Example
  Arthritis & Rheumatology, 2017
• Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate
  Arthritis & Rheumatism, 2013